Investor Relations

Board of Directors

show all hide all

John C. Lechleiter, Ph.D.

Chairman, President, and Chief Executive Officer
Eli Lilly and Company

John C. Lechleiter, Ph.D., is chairman, president, and chief executive officer of Eli Lilly and Company. Lechleiter served previously as president and chief operating officer of Lilly, beginning in 2005, when he also joined the board. In 2004, he became Lilly's executive vice president for pharmaceutical operations. Prior to that, he had served as executive vice president for pharmaceutical products and corporate development since 2001.

Lechleiter received a bachelor of science degree in chemistry from Xavier University (Cincinnati, Ohio) in 1975. He subsequently studied organic chemistry as a National Science Foundation Fellow at Harvard University, where he received his master's and doctorate degrees. In 2006, Lechleiter received an honorary doctorate of business administration from Marian University (Indianapolis).

Joining Lilly in 1979 as a senior organic chemist in process research and development, Lechleiter became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England.

He returned to the United States in 1986 as manager of research and development projects for Europe. In 1988, he became director of development projects management, and in 1989, he assumed additional responsibility for pharmaceutical regulatory affairs. In 1991, he was named executive director of pharmaceutical product development, and in 1993, he became vice president. He was appointed vice president of regulatory affairs in 1994. In 1996, he was named vice president for development and regulatory affairs. Lechleiter became senior vice president of pharmaceutical products in 1998.

He is a member of the American Chemical Society; Business Roundtable; and Business Council. Currently, Lechleiter serves on the boards of the Pharmaceutical Research and Manufacturers of America (PhRMA); Nike, Inc.; Xavier University; Fairbanks Institute (Indianapolis); Indianapolis Downtown, Inc.; the Central Indiana Corporate Partnership; and the United Way of Central Indiana.

Chairman of the Board

Ralph Alvarez

President and Chief Operating Officer
McDonald's Corporation

Ralph Alvarez is president and chief operating officer of McDonald's Corporation. He was elected to the board of directors of Eli Lilly and Company effective April 1, 2009.

Born in Cuba, he received his bachelor's degree in business administration from the University of Miami.

Prior to joining McDonald's, he held leadership positions at Burger King Corporation and Wendy's International, Inc. Alvarez joined McDonald's in 1994. He has held a variety of leadership roles throughout his career, including chief operations officer and president of the central division, both with McDonald's USA. Before joining the U.S. business, Alvarez was president of McDonald's Mexico. From July 2004 until January 2005, he was president of McDonald's USA, where he led a team that aligned employees, owner/operators, and suppliers behind the company's "Plan to Win" strategy–the catalyst for the turnaround of the U.S. business. Alvarez served as president of McDonald's North America from January 2005 until August 2006. In this role, he was responsible for all the McDonald's restaurants in the U.S. and Canada. Alvarez became president and chief operating officer in August 2006. He sets the global strategy and directs operations for the nearly 32,000 McDonald's restaurants in 118 countries. He leads the worldwide senior management team as they drive business results to create value for McDonald's and its shareholders.

An active advocate for Ronald McDonald House Charities, Alvarez is a former president of Ronald McDonald House Charities in Mexico. Alvarez serves on the board of McDonald's Corporation. He currently serves on the President's Council and the International Advisory Board of the University of Miami, and he is a member of the board of trustees for Chicago's Field Museum.

Member of the Board
Member of the Finance Committee
Member of the Public Policy and Compliance Committee

Sir Winfried Bischoff

Chairman
Lloyds Banking Group plc

Sir Winfried Bischoff is chairman of Lloyds Banking Group plc. He was elected to the board of directors of Eli Lilly and Company in April 2000.

After early education in Cologne and Dusseldorf, Germany, he moved to South Africa in 1955 and obtained a bachelor of commerce degree at the University of the Witwatersrand in Johannesburg in 1961. From 1962 to 1963, he was attached to the international department of Chase Manhattan Bank in New York.

Bischoff joined the company finance division of J. Henry Schroder & Co. Limited, London (the London Investment Bank of the Schroder Group) in 1966 and transferred to the bank's international issues department in 1970. The next year, he was appointed managing director of Schroders Asia Limited, Hong Kong. In 1983, he returned to London in charge of the company finance division of J. Henry Schroder & Co. He was appointed chairman of J. Henry Schroder & Co. in 1983, and, in addition, group chief executive of Schroders plc in 1984. In 1995, he was named chairman of Schroders plc. Following the acquisition of Schroders' investment banking business by Citigroup, he served as chairman of Citigroup Europe from 2000 to 2009. He served as chairman of Citigroup Inc. from December 2007 until February 2009. He was appointed to his present position on September 15, 2009.

He is a nonexecutive director of The McGraw-Hill Companies, Inc. He is a past member of the boards of Siemens Holdings plc; Cable and Wireless plc; IFIL Finanziaria di Partecipazioni SPA, Italy; Land Securities plc; and Prudential plc.

He is a member of the City Promotion Panel. He was awarded a knighthood in the New Year Honours list in 2000 and is chairman of UK Careers Academy.

Member of the Board
Member of the Directors and Corporate Governance Committee
Chairman of the Finance Committee

Michael L. Eskew

Former Chairman and Chief Executive Officer
United Parcel Service, Inc.

Michael L. Eskew is the retired chairman and chief executive officer of United Parcel Service, Inc., a position he held from January 2002 until December 2007. He continues to serve on the UPS board of directors. He was elected to the Eli Lilly and Company board of directors in February 2008.

A native of Vincennes, Indiana, Eskew graduated from Purdue University with a bachelor's degree in industrial engineering. He also completed the advanced management program at the Wharton School of Business.

Eskew serves as the chairman of the board of trustees of The Annie E. Casey Foundation, which is the country's largest foundation dedicated to disadvantaged youth. He also serves on the boards of directors of the 3M Corporation and IBM Corporation.

Member of the Board
Chairman of the Audit Committee
Member of the Compensation Committee

Martin S. Feldstein, Ph.D.

George F. Baker Professor of Economics
Harvard University

Martin S. Feldstein, Ph.D., is the George F. Baker Professor of Economics at Harvard University and president emeritus of the National Bureau of Economic Research. He has been a member of the board of directors of Eli Lilly and Company since 2002.

A native of New York, he received a bachelor's degree, summa cum laude, from Harvard College in 1961, and from Oxford University, he obtained a bachelor's degree in 1963, a master's degree in 1964, and a doctorate in 1967.

From 1982 through 1984, Feldstein served as chairman of the Council of Economic Advisers and President Ronald Reagan's chief economic advisor. He served as president of the American Economic Association in 2004. In 2006, President Bush appointed Feldstein as a member of the President's Foreign Intelligence Advisory Board. He served as president and chief executive officer of the National Bureau of Economic Research from 1977 to 1982 and 1984 to 2008. In 2009, President Obama appointed Feldstein as a member of the President's Economic Recovery Advisory Board.

He is a member of the American Philosophical Society, a corresponding fellow of the British Academy, a fellow of the Econometric Society, and a fellow of the National Association of Business Economics. Feldstein is a trustee of the Council on Foreign Relations and a member of the Trilateral Commission, the Group of 30, the American Academy of Arts and Sciences, and the Council of Academic Advisors of the American Enterprise Institute.

He is an economic advisor to several businesses and government organizations in the United States and abroad. Additionally, he is a regular contributor to The Wall Street Journal and other publications and has authored more than 300 research articles in economics.

Feldstein has received honorary doctorates from several universities and is an honorary fellow of Nuffield College, Oxford. He is the 1977 recipient of the John Bates Clark Medal of the American Economic Association, a prize awarded every two years to the economist under the age of 40 who is judged to have made the greatest contribution to economic science.

Member of the Board
Member of the Audit Committee
Member of the Finance Committee
Chairman of the Public Policy and Compliance Committee

J. Erik Fyrwald

Chairman, President, and Chief Executive Officer
Nalco Company

J. Erik Fyrwald joined Nalco Company as chairman, president, and chief executive officer in February 2008 following a 27-year career at DuPont. He was elected to the Eli Lilly and Company board of directors in 2005.

From 2003 to 2008, Fyrwald served as group vice president of the agriculture and nutrition division at E.I. du Pont de Nemours and Company. From 2000 until 2003, he was vice president and general manager of DuPont's nutrition and health business.

Fyrwald attended the University of Delaware, where he received a bachelor of science degree in chemical engineering in 1981. He also completed the advanced management program at Harvard Business School.

In addition to serving as chairman of Nalco's board of directors, Fyrwald serves as a director of the Society of Chemical Industry and the American Chemistry Council.

Member of the Board
Member of the Compensation Committee
Member of the Science and Technology Committee

Alfred G. Gilman, M.D., Ph.D.

Chief Scientific Officer
Cancer Prevention and Research Institute of Texas

Alfred G. Gilman, M.D., Ph.D., chief scientific officer, Cancer Prevention and Research Institute of Texas; was elected to the board of directors of Eli Lilly and Company in 1995. He also holds the position of regental professor of pharmacology emeritus at the University of Texas Southwestern Medical Center at Dallas.

Born in New Haven, Connecticut, he received a bachelor of science degree summa cum laude in biochemistry in 1962 from Yale University and his doctor of medicine degree and doctorate in pharmacology in 1969 from Case Western Reserve University. He received further training as a pharmacology research associate in the Laboratory of Biochemical Genetics at the National Institutes of Health beginning in 1969. In 1971, he began a ten-year stay at the University of Virginia School of Medicine in Charlottesville where his positions included assistant, associate, and professor of pharmacology, and director of the medical scientist training program.

He is a member of the board of directors of Regeneron Pharmaceuticals, Inc. He was the editor of Goodman and Gilman's The Pharmacological Basis of Therapeutics from 1980-1990.

Gilman has been the recipient of many awards including: the Nobel Prize in Physiology or Medicine (1994), American Heart Association Basic Science Research Prize (1990), American Cancer Society Medal of Honor (1995), Albert Lasker Basic Medical Research Award (1989), election to the National Academy of Sciences (1985), and The Gairdner Foundation International Award (1984). He has received honorary degrees from the University of Chicago (1990), Case Western Reserve University (1995), Yale University (1997), and the University of Miami (1999).

Member of the Board
Member of the Public Policy and Compliance Committee
Chairman of the Science and Technology Committee

R. David Hoover

Chairman, President, and Chief Executive Officer
Ball Corporation

R. David Hoover is chairman, president, and chief executive officer of Ball Corporation, a provider of metal and plastic packaging for beverages, foods and household products, and of aerospace and other technologies and services to commercial and governmental customers. He was elected to the board of directors of Eli Lilly and Company effective June 1, 2009.

A native of Straughn, Indiana, he received a bachelor's degree in economics from DePauw University in 1967 and his MBA in finance and real estate from Indiana University in 1970. He also completed the advanced management program at Harvard University Graduate School of Business, Boston, in 1988.

Hoover has been the chairman, president, and chief executive officer of Ball Corporation since April 2002 having been elected president and chief executive officer in January 2001. Hoover joined Ball Corporation in 1970. During his career, he has served as vice president, finance and administration, of both the company's agricultural systems division and the company's aerospace systems group. He was elected vice president and treasurer in 1988 and senior vice president and chief financial officer in 1992. He was named executive vice president and elected to the company's board of directors in 1996. In 1998, he was elected vice chairman, in addition to the role of chief financial officer. Hoover became president of Ball Corporation in January 2000, and was named chief operating officer in April 2000.

Hoover is a member of the boards of Ball Corporation; Energizer Holdings, Inc.; and Qwest Communications International Inc. He is a member of the board of the National Association of Manufacturers and is a member and past chair of the board of governors of the Can Manufacturers Institute (CMI). Hoover is chair of the board of trustees of DePauw University and on the Indiana University Kelley School of Business Dean's Council. He is also a director of Boulder Community Hospital and a member of the Colorado Forum.

Member of the Board
Member of the Audit Committee
Member of the Compensation Committee

Karen N. Horn, Ph.D.

Retired President, Private Client Services, and Managing Director
Marsh, Inc.

Karen N. Horn, Ph.D., served as president, private client services, and managing director of Marsh, Inc. from 1999 until her retirement in 2003. She was elected to the board of directors of Eli Lilly and Company in 1987.

She earned a bachelor of arts degree in mathematics and economics from Pomona College and holds a doctor of philosophy degree in economics from The Johns Hopkins University. Her previous experience includes senior managing director and head of international private banking, Bankers Trust Company; chairman and chief executive officer of Bank One, Cleveland, N.A.; president of the Federal Reserve Bank of Cleveland; treasurer of Bell Telephone Company of Pennsylvania; and vice president of First National Bank of Boston.

Horn has been senior managing director of Brock Capital Group since 2004. She is a director of T. Rowe Price Mutual Funds; The U.S. Russia Investment Fund, a presidential appointment; Simon Property Group, Inc.; and Norfolk Southern Corporation. Also, she served on the President's Bipartisan Commission on Entitlements.

Presiding Director of the Board
Chairman of the Compensation Committee
Member of the Directors and Corporate Governance Committee

Ellen R. Marram

President
The Barnegat Group LLC

Ellen R. Marram is the president of The Barnegat Group LLC, a firm that provides business advisory services. She was a managing director at North Castle Partners, LLC from 2000 to 2005 and is currently an advisor to the firm. Prior to joining North Castle, she served as the chief executive officer of a start-up B2B exchange for the food and beverage industry. Marram has been a member of the board of directors of Eli Lilly and Company since 2002.

From 1993 to 1998, Marram was president and chief executive officer of Tropicana and the Tropicana Beverage Group. She steadily grew revenue and earnings and nearly doubled margins as she transformed Tropicana from a Florida juice company to a market-driven, health-focused, global juice business, number one in worldwide sales and profits. During Marram's tenure, Tropicana nearly tripled its shareholder value and was sold to PepsiCo in 1998 for $3.3 billion.

From 1988 to 1993, Marram was president and chief executive officer of the Nabisco Biscuit Company, the largest operating unit of Nabisco, Inc. Under her leadership, the company significantly increased sales and margins and had one of the most successful new product records in the food industry. Marram's vision and direction led to the 1992 launch of SnackWell's cookies and crackers, which pioneered low fat snacking and is considered one of the most successful new products of the 1990s.

From 1987 to 1988, Marram was president of Nabisco's grocery division. From 1970 to 1986, she held a series of marketing positions at Nabisco/Standard Brands, Johnson & Johnson, and Lever Brothers.

Marram is a member of the board of directors of Ford Motor Company and The New York Times Company, as well as several private companies. She also serves on the boards of Institute for the Future, The New York-Presbyterian Hospital, Lincoln Center Theater, Families and Work Institute, and Citymeals-on-Wheels. She is a past member of the board of associates of Harvard Business School and a past trustee of the Conference Board.

She is a 1968 graduate of Wellesley College and earned an MBA in 1970 from Harvard Business School, and has received alumni achievement awards from both institutions. She was named one of the Top 25 Managers of the Year by Business Week in January 1998.

Member of the Board
Member of the Compensation Committee
Chairman of the Directors and Corporate Governance Committee

Douglas R. Oberhelman

Group President
Caterpillar Inc.

Douglas R. Oberhelman is a group president of Caterpillar Inc. in Peoria, Illinois. He has responsibility for the company's human services and sustainable development functions, as well as Caterpillar's growing remanufacturing business. He also oversees worldwide manufacturing, marketing and support of industrial and large power systems, industrial gas turbines, and Progress Rail Services. Oberhelman was elected to the Eli Lilly and Company board of directors in 2008.

Oberhelman was elected a vice president in 1995, serving as Caterpillar's chief financial officer with administrative responsibility for the corporation's accounting, information services, tax, treasury, investor relations and marketing support services areas from 1995 to November 1998. In 1998, he became vice president with responsibility for the engine products division, including the market development, strategic planning, supplier management, electric power generation and worldwide marketing and administration for Caterpillar's engine business. He was elected a group president and member of Caterpillar's executive office in 2002.

Oberhelman joined Caterpillar in 1975 and has held a variety of positions, including senior finance representative based in South America for Caterpillar Americas Co; region finance manager and district manager for the company's North American commercial division; and managing director and vice general manager for strategic planning at Caterpillar Japan Ltd.

He has a bachelor's degree from Millikin University. He has served as chairman of the board of trustees for Millikin University and chairman of the board of directors for Easter Seals, and he is a former director for the boards of South Side Bank, Millikin University, and Easter Seals. He is a director for the boards of The Nature Conservancy - Illinois Chapter and Ameren Corporation. He is also a member of the board of directors of the National Association of Manufacturers, the Manufacturing Institute, and the Wetlands America Trust.

Member of the Board
Member of the Audit Committee
Member of the Finance Committee

Franklyn G. Prendergast, M.D., Ph.D.

Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics
Mayo Medical School
Director
Mayo Clinic Center for Individualized Medicine
Director Emeritus
Mayo Clinic Cancer Center

Franklyn G. Prendergast, M.D., Ph.D., Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School; director, Mayo Clinic Center for Individualized Medicine; and director emeritus, Mayo Clinic Cancer Center, was elected to the board of directors of Eli Lilly and Company in April 1995.

Born in Linstead, Jamaica, he received a degree in medicine from the University of the West Indies in 1968. A Rhodes Scholar, he received a bachelor of arts degree in physiology from Oxford University in 1971, his doctorate in biochemistry from the University of Minnesota in 1977, and a master's degree in physiology from Oxford University in 1979.

Prendergast began his career at the Mayo Medical School as an instructor in physiology in 1975. In 1977 he became associate consultant in pharmacology at the Mayo Foundation and assistant professor in pharmacology of the Mayo Medical School. Three years later he was named consultant in pharmacology at the Mayo Foundation and associate professor in pharmacology at the Mayo Medical School. In 1985 he became consultant and chair of the department of biochemistry and molecular biology for the Mayo Foundation. He became professor in pharmacology and professor in biochemistry and molecular biology at the Mayo Medical School in 1986. He was named director of research for Mayo Rochester in 1992. He serves on the board of trustees of the Mayo Foundation.

Prendergast has been the recipient of numerous honors and awards, including Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology (1987) and Mayo Distinguished Investigator (1988). He is a member of the American Chemical Society, American Association for the Advancement of Science, Biophysical Society, Sigma Xi, the American Society for Biochemistry and Molecular Biology, and the American Cancer Society.

Member of the Board
Member of the Public Policy and Compliance Committee
Member of the Science and Technology Committee

Kathi P. Seifert

Retired Executive Vice President
Kimberly-Clark Corporation

Kathi P. Seifert, retired executive vice president for Kimberly-Clark Corporation, was elected to the board of directors of Eli Lilly and Company in 1995.

A native of Appleton, Wisconsin, she received a bachelor of science degree from Valparaiso University.

Prior to joining Kimberly-Clark in 1978, Seifert held management positions at Procter & Gamble, Beatrice Foods, and Fort Howard Paper Company. She joined Kimberly-Clark as a product manager and held several marketing positions before being elected to her most recent position in November 1999. She retired in June 2004.

Seifert is chairman of Katapult, LLC; a member of the board of directors of Supervalu Inc.; Revlon Consumer Products Corporation; Lexmark International, Inc.; Appleton Papers Inc.; the U.S. Fund for UNICEF; and the Fox Cities Performing Arts Center.

Member of the Board
Member of the Audit Committee
Member of the Public Policy and Compliance Committee